{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:03:09Z","timestamp":1780023789618,"version":"3.53.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pulmonary fibrosis (PF) is an interstitial lung disease with macrophage polarization playing a critical role. Previous research has demonstrated that essential oil from\n                      <jats:italic>Radix Curcumae<\/jats:italic>\n                      (RCEO) significantly ameliorates pulmonary sarcoidosis, an effect attributed to the modulation of macrophage polarization. However, the therapeutic potential of RCEO in PF and its underlying mechanisms remain to be elucidated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate whether RCEO ameliorates pulmonary function in PF mice by suppressing the polarization of M1 and M2 macrophages via suppressing the Pi3k\/Akt\/\u03b2-catenin and Tlr4\/Myd88\/Nf-\u03bab signaling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bioinformatics and network pharmacology approaches were employed to predict the potential therapeutic targets of RCEO for PF. The main components of RCEO and the primary constituents of RCEO deposited in lung tissue following inhalation were analyzed using GC\u2013MS. PF models were established both in vivo and in vitro using bleomycin. Changes in pulmonary function were assessed by whole-body plethysmography. HE staining and Masson staining were used to observe histopathological alterations and fibrosis progression in lung tissues. ELISA was performed to measure changes in fibrosis-related mediators in blood. Flow cytometry was utilized to investigate macrophage polarization and apoptosis levels in lung tissues. Immunofluorescence analysis was applied to quantify the expression and distribution of Tlr4 and Pi3k, as well as their fluorescence co-localization with macrophages, in lung tissues. PCR and WB were conducted to evaluate changes in mRNA expression levels and protein abundance associated with the Tlr4\/Myd88\/Nf-\u03bab and Pi3k\/Akt\/\u03b2-catenin signaling pathways in lung tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Bioinformatics and Network Pharmacology analyses predicted that the therapeutic effect of RCEO on PF is associated with the modulation of macrophage differentiation via the Tlr4\/Myd88\/Nf-\u03bab pathway and the Pi3k\/Akt\/\u03b2-catenin signaling pathway. In a PF mouse model, RCEO significantly alleviated pathological alterations and collagen deposition in lung tissues and improved pulmonary function. Results from both in vivo and in vitro flow cytometry demonstrated that RCEO concurrently suppressed the differentiation of macrophages into both M1 and M2 phenotypes, promoted apoptosis in 3T3 cells while inhibiting apoptosis in MLE-12 cells, and reduced the levels of profibrotic mediators. Further PCR and Western blot analyses indicated that RCEO modulates macrophage polarization and extracellular matrix expression by inhibiting the Tlr4\/Myd88\/Nf-\u03bab and Pi3k\/Akt\/\u03b2-catenin signaling pathways. Immunofluorescence assays revealed that RCEO effectively downregulated the expression of Tlr4 and Pi3k in macrophages, thereby exerting a protective effect against pulmonary fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RCEO ameliorates PF by suppressing both M1 and M2 polarization of macrophages via inhibition of the Pi3k\/Akt\/\u03b2-catenin and Tlr4\/Myd88\/Nf-\u03bab signaling pathways. This leads to reduced release of pro-inflammatory and pro-fibrotic cytokines, decreased extracellular matrix (ECM) deposition, and overall attenuation of fibrotic progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01398-w","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:40:51Z","timestamp":1780022451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the role of RCEO in macrophage-mediated modulation of pulmonary fibrosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhiguo","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"2","key":"1398_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1164\/rccm.202405-0977OC","volume":"211","author":"TJ Corte","year":"2025","unstructured":"Corte TJ, Behr J, Cottin V, Glassberg MK, Kreuter M, Martinez FJ, et al. Efficacy and safety of Admilparant, an LPA(1) antagonist, in pulmonary fibrosis: a Phase 2 randomized clinical trial. Am J Respir Crit Care Med. 2025;211(2):230\u20138. https:\/\/doi.org\/10.1164\/rccm.202405-0977OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8057","key":"1398_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-024-08542-2","volume":"640","author":"Y Fang","year":"2025","unstructured":"Fang Y, Chung SSW, Xu L, Xue C, Liu X, Jiang D, et al. RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition. Nature. 2025;640(8057):221\u201330. https:\/\/doi.org\/10.1038\/s41586-024-08542-2.","journal-title":"Nature"},{"key":"1398_CR3","doi-asserted-by":"publisher","DOI":"10.1172\/jci184158","author":"L Xu","year":"2025","unstructured":"Xu L, Li T, Cao Y, He Y, Shao Z, Liu S, et al. PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/jci184158.","journal-title":"J Clin Invest"},{"issue":"1","key":"1398_CR4","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41467-025-56922-7","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu J, Li Y, Li Y, Liu X, Huo Q, Wu N, et al. Phosphorylation of FOXN3 by NEK6 promotes pulmonary fibrosis through Smad signaling. Nat Commun. 2025;16(1):1865. https:\/\/doi.org\/10.1038\/s41467-025-56922-7.","journal-title":"Nat Commun"},{"key":"1398_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156545","volume":"140","author":"Q Mao","year":"2025","unstructured":"Mao Q, Liu J, Yan Y, Wang G, Zhang M, Wang Z, et al. 13-Methylpalmatine alleviates bleomycin-induced pulmonary fibrosis by suppressing the ITGA5\/TGF-\u03b2\/Smad signaling pathway. Phytomedicine. 2025;140:156545. https:\/\/doi.org\/10.1016\/j.phymed.2025.156545.","journal-title":"Phytomedicine"},{"key":"1398_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.138238","volume":"492","author":"C Huo","year":"2025","unstructured":"Huo C, Jia Q, Jiao X, Jiang Q, Zeng X, Zhang J, et al. Pulmonary microbiota affects silica-induced pulmonary fibrosis through activation of the PI3K\/AKT-mediated senescence in alveolar epithelial cells. J Hazard Mater. 2025;492:138238. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.138238.","journal-title":"J Hazard Mater"},{"key":"1398_CR7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00752-2023","author":"M Wijsenbeek","year":"2024","unstructured":"Wijsenbeek M, Swigris JJ, Inoue Y, Kreuter M, Maher TM, Suda T, et al. Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.00752-2023.","journal-title":"Eur Respir J"},{"key":"1398_CR8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01484-2024","author":"HY Yoon","year":"2025","unstructured":"Yoon HY, Kim H, Bae Y, Song JW. Pirfenidone and risk of lung cancer development in idiopathic pulmonary fibrosis: a nationwide population-based study. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.01484-2024.","journal-title":"Eur Respir J"},{"issue":"7","key":"1398_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407134","volume":"12","author":"W Sun","year":"2025","unstructured":"Sun W, Zhou S, Peng L, Wang W, Liu Y, Wang T, et al. Fatty acid oxidation-glycolysis metabolic transition affects ECM homeostasis in silica-induced pulmonary fibrosis. Adv Sci. 2025;12(7):e2407134. https:\/\/doi.org\/10.1002\/advs.202407134.","journal-title":"Adv Sci"},{"issue":"1","key":"1398_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57024-0","volume":"16","author":"H Cui","year":"2025","unstructured":"Cui H, Banerjee S, Xie N, Hussain M, Jaiswal A, Liu H, et al. TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity. Nat Commun. 2025;16(1):1761. https:\/\/doi.org\/10.1038\/s41467-025-57024-0.","journal-title":"Nat Commun"},{"key":"1398_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.136629","volume":"483","author":"L Zhang","year":"2025","unstructured":"Zhang L, Tian J, Li N, Wang Y, Jin Y, Bian H, et al. Exosomal miRNA reprogramming in pyroptotic macrophage drives silica-induced fibroblast-to-myofibroblast transition and pulmonary fibrosis. J Hazard Mater. 2025;483:136629. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.136629.","journal-title":"J Hazard Mater"},{"issue":"1","key":"1398_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59093-7","volume":"16","author":"J Yan","year":"2025","unstructured":"Yan J, Wang SY, Su Q, Zou MW, Zhou ZY, Shou J, et al. Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile. Nat Commun. 2025;16(1):3748. https:\/\/doi.org\/10.1038\/s41467-025-59093-7.","journal-title":"Nat Commun"},{"key":"1398_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117216","volume":"178","author":"L Long","year":"2024","unstructured":"Long L, Dai X, Yao T, Zhang X, Jiang G, Cheng X, et al. Mefunidone alleviates silica-induced inflammation and fibrosis by inhibiting the TLR4-NF-\u03baB\/MAPK pathway and attenuating pyroptosis in murine macrophages. Biomed Pharmacother. 2024;178:117216. https:\/\/doi.org\/10.1016\/j.biopha.2024.117216.","journal-title":"Biomed Pharmacother"},{"key":"1398_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.168948","volume":"912","author":"Q Jia","year":"2024","unstructured":"Jia Q, Wang H, Wang Y, Xue W, Jiang Q, Wang J, et al. Investigation of the mechanism of silica-induced pulmonary fibrosis: the role of lung microbiota dysbiosis and the LPS\/TLR4 signaling pathway. Sci Total Environ. 2024;912:168948. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.168948.","journal-title":"Sci Total Environ"},{"key":"1398_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155687","volume":"130","author":"L Deng","year":"2024","unstructured":"Deng L, Ouyang B, Tang W, Wang N, Yang F, Shi H, et al. Icariside II modulates pulmonary fibrosis via PI3K\/Akt\/\u03b2-catenin pathway inhibition of M2 macrophage program. Phytomedicine. 2024;130:155687. https:\/\/doi.org\/10.1016\/j.phymed.2024.155687.","journal-title":"Phytomedicine"},{"key":"1398_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155545","volume":"132","author":"C Jia","year":"2024","unstructured":"Jia C, Yang M, Xiao G, Zeng Z, Li L, Li Y, et al. ESL attenuates BLM-induced IPF in mice: dual mediation of the TLR4\/NF-\u03baB and TGF-\u03b21\/PI3K\/Akt\/FOXO3a pathways. Phytomedicine. 2024;132:155545. https:\/\/doi.org\/10.1016\/j.phymed.2024.155545.","journal-title":"Phytomedicine"},{"issue":"7","key":"1398_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41423-025-01288-5","volume":"22","author":"S Li","year":"2025","unstructured":"Li S, Xu H, Liu S, Hou J, Han Y, Li C, et al. Targeting Lp-PLA2 inhibits profibrotic monocyte-derived macrophages in silicosis through restoring cardiolipin-mediated mitophagy. Cell Mol Immunol. 2025;22(7):776\u201390. https:\/\/doi.org\/10.1038\/s41423-025-01288-5.","journal-title":"Cell Mol Immunol"},{"key":"1398_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.174299","volume":"946","author":"H Yuan","year":"2024","unstructured":"Yuan H, He Y, Zhang Y, Min H, Chen J, Li C. Crystalline silica-induced endoplasmic reticulum stress promotes the pathogenesis of silicosis by augmenting proinflammatory interstitial pulmonary macrophages. Sci Total Environ. 2024;946:174299. https:\/\/doi.org\/10.1016\/j.scitotenv.2024.174299.","journal-title":"Sci Total Environ"},{"issue":"3","key":"1398_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5534\/wjmh.240071","volume":"43","author":"GH Lee","year":"2025","unstructured":"Lee GH, Shin YS, Kim JH, Shim DH, Lee HY, Zhao L, et al. The combination of Curcumae Radix and Syzygium Aromaticum extracts mitigates benign prostatic hyperplasia through anti-proliferative and anti-inflammatory effects. World J Mens Health. 2025;43(3):603\u201315. https:\/\/doi.org\/10.5534\/wjmh.240071.","journal-title":"World J Mens Health"},{"issue":"1","key":"1398_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/21691401.2023.2239522","volume":"52","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Kong H, Li Y, Zhao Y, Zhang Y, Zhao Y, et al. Inhibitory effects of Curcumae Radix carbonisata-based carbon dots against liver fibrosis induced by carbon tetrachloride in mice. Artif Cells Nanomed Biotechnol. 2024;52(1):23\u201334. https:\/\/doi.org\/10.1080\/21691401.2023.2239522.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1398_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156496","volume":"139","author":"Z Mao","year":"2025","unstructured":"Mao Z, Lin X, Hu Y, Liu Y, Yu S, Zhou T, et al. Exploring the anti-inflammatory effects of Radix Curcumae essential oil in pulmonary sarcoidosis via the TLR4\/MyD88\/NF-\u03baB pathway. Phytomedicine. 2025;139:156496. https:\/\/doi.org\/10.1016\/j.phymed.2025.156496.","journal-title":"Phytomedicine"},{"key":"1398_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0986-8","volume":"19","author":"J Sun","year":"2019","unstructured":"Sun J, Huang J, Lan J, Zhou K, Gao Y, Song Z, et al. Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer. Cancer Cell Int. 2019;19:264. https:\/\/doi.org\/10.1186\/s12935-019-0986-8.","journal-title":"Cancer Cell Int"},{"issue":"18","key":"1398_CR23","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.2174\/0115701808297938241210072128","volume":"21","author":"L Liu","year":"2024","unstructured":"Liu L, Wang M, Zhang J, Chen W, Zuo W, Zeng Y, et al. The inhibitory effect and mechanism of action of Myricaria germanica essential oils on skin inflammation based on network pharmacology and molecular docking. Lett Drug Des Discov. 2024;21(18):4484\u201399. https:\/\/doi.org\/10.2174\/0115701808297938241210072128.","journal-title":"Lett Drug Des Discov"},{"issue":"4","key":"1398_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2174\/1570180820666230110155743","volume":"21","author":"C Li","year":"2024","unstructured":"Li C, Su F, Zhang L, Liu F, Li Z, Fan WX, et al. Based on the network pharmacology to analyze the effect of Chuanxiong in improving diabetic nephropathy. Lett Drug Des Discov. 2024;21(4):709\u201317. https:\/\/doi.org\/10.2174\/1570180820666230110155743.","journal-title":"Lett Drug Des Discov"},{"issue":"W1","key":"1398_CR25","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao ZX, Cao Y. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50(W1):W159-w164. https:\/\/doi.org\/10.1093\/nar\/gkac394.","journal-title":"Nucleic Acids Res"},{"key":"1398_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155755","volume":"132","author":"F Liu","year":"2024","unstructured":"Liu F, Yao Y, Guo C, Dai P, Huang J, Peng P, et al. Trichodelphinine A alleviates pulmonary fibrosis by inhibiting collagen synthesis via NOX4-ARG1\/TGF-\u03b2 signaling pathway. Phytomedicine. 2024;132:155755. https:\/\/doi.org\/10.1016\/j.phymed.2024.155755.","journal-title":"Phytomedicine"},{"issue":"7","key":"1398_CR27","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.7150\/thno.94482","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang T, Liang F, Han J, Lou Z, Yu Y, et al. Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice. Theranostics. 2024;14(7):2794\u2013815. https:\/\/doi.org\/10.7150\/thno.94482.","journal-title":"Theranostics"},{"key":"1398_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ph17101360","author":"EA Tukhovskaya","year":"2024","unstructured":"Tukhovskaya EA, Palikova YA, Severyukhina MS, Ismailova AM, Palikov VA, Slashcheva GA, et al. Comparison of the results of modeling pulmonary fibrosis in Sprague Dawley rats by intratracheal administration of Bleomycin in the form of Sulfate and Chloride at a dose of 3 mg\/kg. Pharmaceuticals (Basel, Switzerland). 2024. https:\/\/doi.org\/10.3390\/ph17101360.","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"1","key":"1398_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/13880209.2022.2160767","volume":"61","author":"J-H Y","year":"2023","unstructured":"Y J-H, Yu M, Y L-H, G J-J, X L-L, Lv W, et al. Baicalein attenuates bleomycin-induced lung fibroblast senescence and lung fibrosis through restoration of Sirt3 expression. Pharm Biol. 2023;61(1):288\u201397. https:\/\/doi.org\/10.1080\/13880209.2022.2160767.","journal-title":"Pharm Biol"},{"issue":"1","key":"1398_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41467-023-36314-5","volume":"14","author":"L Tanner","year":"2023","unstructured":"Tanner L, Single AB, Bhongir RKV, Heusel M, Mohanty T, Karlsson CAQ, et al. Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model. Nat Commun. 2023;14(1):643. https:\/\/doi.org\/10.1038\/s41467-023-36314-5.","journal-title":"Nat Commun"},{"key":"1398_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156314","volume":"136","author":"Q Feng","year":"2025","unstructured":"Feng Q, Yu X, Xie J, Liu F, Zhang X, Li S, et al. Phillygenin improves diabetic nephropathy by inhibiting inflammation and apoptosis via regulating TLR4\/MyD88\/NF-\u03baB and PI3K\/AKT\/GSK3\u03b2 signaling pathways. Phytomedicine. 2025;136:156314. https:\/\/doi.org\/10.1016\/j.phymed.2024.156314.","journal-title":"Phytomedicine"},{"issue":"1","key":"1398_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07779-7","volume":"16","author":"D Huang","year":"2025","unstructured":"Huang D, Xu M, Wang H, Zhao Y, Zhang Z, Yu M, et al. SIRP\u03b1 blockade therapy potentiates immunotherapy by inhibiting PD-L1(+) myeloid cells in hepatocellular carcinoma. Cell Death Dis. 2025;16(1):451. https:\/\/doi.org\/10.1038\/s41419-025-07779-7.","journal-title":"Cell Death Dis"},{"issue":"20","key":"1398_CR33","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, et al. USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer. Theranostics. 2020;10(20):9332\u201347. https:\/\/doi.org\/10.7150\/thno.47137.","journal-title":"Theranostics"},{"issue":"2","key":"1398_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/0118744710336823241011095632","volume":"18","author":"F Rajabinasab","year":"2025","unstructured":"Rajabinasab F, Hajimirzaei P, Ramezani F, Moayer F, Gorjipour F, Nikoofar A, et al. Apigenin\u2019s influence on inflammatory and epigenetic responses in rat lungs after radiotherapy. Curr Radiopharm. 2025;18(2):147\u201357. https:\/\/doi.org\/10.2174\/0118744710336823241011095632.","journal-title":"Curr Radiopharm"},{"issue":"1","key":"1398_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02011-y","volume":"9","author":"G Huang","year":"2024","unstructured":"Huang G, Yang X, Yu Q, Luo Q, Ju C, Zhang B, et al. Overexpression of STX11 alleviates pulmonary fibrosis by inhibiting fibroblast activation via the PI3K\/AKT\/mTOR pathway. Signal Transduct Target Ther. 2024;9(1):306. https:\/\/doi.org\/10.1038\/s41392-024-02011-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"1398_CR36","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/s12276-024-01277-0","volume":"56","author":"W Su","year":"2024","unstructured":"Su W, Guo Y, Wang Q, Ma L, Zhang Q, Zhang Y, et al. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis. Exp Mol Med. 2024;56(7):1643\u201354. https:\/\/doi.org\/10.1038\/s12276-024-01277-0.","journal-title":"Exp Mol Med"},{"key":"1398_CR37","doi-asserted-by":"publisher","first-page":"18761429246636","DOI":"10.2174\/0118761429246636230919122745","volume":"17","author":"M Tavakkoli","year":"2024","unstructured":"Tavakkoli M, Khodashahi R, Aliakbarian M, Rahimi H, Ashrafzadeh K, Ferns G, et al. Review of the role of metabolic factors in determining the post-surgical adhesion and its therapeutic implications, with a focus on extracellular matrix and oxidative stress. Curr Mol Pharmacol. 2024;17:18761429246636. https:\/\/doi.org\/10.2174\/0118761429246636230919122745.","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"1398_CR38","doi-asserted-by":"publisher","first-page":"968","DOI":"10.7150\/ijbs.90808","volume":"20","author":"J Wu","year":"2024","unstructured":"Wu J, Gong L, Li Y, Liu T, Sun R, Jia K, et al. SGK1 aggravates idiopathic pulmonary fibrosis by triggering H3k27ac-mediated macrophage reprogramming and disturbing immune homeostasis. Int J Biol Sci. 2024;20(3):968\u201386. https:\/\/doi.org\/10.7150\/ijbs.90808.","journal-title":"Int J Biol Sci"},{"key":"1398_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.bioactmat.2023.09.019","volume":"32","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wan Z, Qu D, Sun W, Zhang L, Liang Y, et al. Profibrogenic macrophage-targeted delivery of mitochondrial protector via exosome formula for alleviating pulmonary fibrosis. Bioact Mater. 2024;32:488\u2013501. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.09.019.","journal-title":"Bioact Mater"},{"key":"1398_CR40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00615-2024","author":"DH Kim","year":"2025","unstructured":"Kim DH, Kim HC, Im K, Baek IJ, Choi YJ, Lee H, et al. Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.00615-2024.","journal-title":"Eur Respir J"},{"key":"1398_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113862","volume":"383","author":"S Zheng","year":"2025","unstructured":"Zheng S, Zhou Z, Ji J, Liu Y, Jiao X, Li X, et al. M2 macrophage-targeted metal-polyphenol networks (MPNs) for OPN siRNA delivery and idiopathic pulmonary fibrosis therapy. J Control Release. 2025;383:113862. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113862.","journal-title":"J Control Release"},{"issue":"3","key":"1398_CR42","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ymthe.2024.01.022","volume":"32","author":"C Li","year":"2024","unstructured":"Li C, Feng X, Li S, He X, Luo Z, Cheng X, et al. Tetrahedral DNA loaded siCCR2 restrains M1 macrophage polarization to ameliorate pulmonary fibrosis in chemoradiation-induced murine model. Mol Ther. 2024;32(3):766\u201382. https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.022.","journal-title":"Mol Ther"},{"key":"1398_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.139286","volume":"496","author":"L Shi","year":"2025","unstructured":"Shi L, Zhang L, Ma Z, Hu Z, Geng Z, Liu H, et al. H3K18 lactylation drives the progression of silica nanoparticles-induced pulmonary fibrosis via promoting macrophage M1 polarization. J Hazard Mater. 2025;496:139286. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.139286.","journal-title":"J Hazard Mater"},{"key":"1398_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2025.109354","volume":"197","author":"PP Cheng","year":"2025","unstructured":"Cheng PP, He XL, Jia ZH, Hu SH, Feng X, Jiang YH, et al. Midkine, a novel MCP-1 activator mediated PM2.5-aggravated experimental pulmonary fibrosis. Environ Int. 2025;197:109354. https:\/\/doi.org\/10.1016\/j.envint.2025.109354.","journal-title":"Environ Int"},{"key":"1398_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.133713","volume":"467","author":"D Cheng","year":"2024","unstructured":"Cheng D, Lian W, Wang T, Xi S, Jia X, Li Z, et al. The interplay of Cxcl10(+)\/Mmp14(+) monocytes and Ccl3(+) neutrophils proactively mediates silica-induced pulmonary fibrosis. J Hazard Mater. 2024;467:133713. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.133713.","journal-title":"J Hazard Mater"},{"key":"1398_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2023.132489","volume":"460","author":"Y You","year":"2023","unstructured":"You Y, Yuan H, Min H, Li C, Chen J. Fibroblast-derived CXCL14 aggravates crystalline silica-induced pulmonary fibrosis by mediating polarization and recruitment of interstitial macrophages. J Hazard Mater. 2023;460:132489. https:\/\/doi.org\/10.1016\/j.jhazmat.2023.132489.","journal-title":"J Hazard Mater"},{"key":"1398_CR47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01544-2023","author":"MM Mia","year":"2025","unstructured":"Mia MM, Ghani S, Cibi DM, Bogireddi H, Nilanthi U, Selvan A, et al. YAP\/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.01544-2023.","journal-title":"Eur Respir J"},{"key":"1398_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103255","volume":"75","author":"Z Feng","year":"2024","unstructured":"Feng Z, Meng F, Huo F, Zhu Y, Qin Y, Gui Y, et al. Inhibition of ferroptosis rescues M2 macrophages and alleviates arthritis by suppressing the HMGB1\/TLR4\/STAT3 axis in M1 macrophages. Redox Biol. 2024;75:103255. https:\/\/doi.org\/10.1016\/j.redox.2024.103255.","journal-title":"Redox Biol"},{"key":"1398_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119631","volume":"345","author":"S Pu","year":"2025","unstructured":"Pu S, Meng X, Shi Y, Huang N, Zhang C, Pang A, et al. Fermented Cordyceps powder alleviates silica-induced inflammation and fibrosis by inhibiting M1 macrophage polarization via the HMGB1-TLR4-NF-\u03baB pathway. J Ethnopharmacol. 2025;345:119631. https:\/\/doi.org\/10.1016\/j.jep.2025.119631.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1398_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02888-5","volume":"22","author":"Z Xue","year":"2024","unstructured":"Xue Z, Liu J, Xing W, Mu F, Wu Y, Zhao J, et al. Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway. J Nanobiotechnol. 2024;22(1):628. https:\/\/doi.org\/10.1186\/s12951-024-02888-5.","journal-title":"J Nanobiotechnol"},{"key":"1398_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177873","volume":"1002","author":"AG Sakr","year":"2025","unstructured":"Sakr AG, Kafl HE, El-Kashef DH. Rupatadine modulates TLR4\/MYD88\/NF-\u03baB and AKT\/PI3K signaling pathways, attenuating sepsis-induced liver injury in mice. Eur J Pharmacol. 2025;1002:177873. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177873.","journal-title":"Eur J Pharmacol"},{"key":"1398_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116192","volume":"307","author":"N Hu","year":"2023","unstructured":"Hu N, Qu Y, Liu TY, Zhou Y, Liu C, Wang JH, et al. Immunomodulatory effects and mechanisms of Tiepishihu Xiyangshen granules on cyclophosphamide induced immuno-suppression via TLR4\/MAPKs and PI3K\/AKT\/FOXO3a signal pathways. J Ethnopharmacol. 2023;307:116192. https:\/\/doi.org\/10.1016\/j.jep.2023.116192.","journal-title":"J Ethnopharmacol"},{"key":"1398_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115249","volume":"163","author":"H Zhu","year":"2025","unstructured":"Zhu H, Wang W, Yang H, Xue L, Chen W, Zhao P, et al. Cyclobenzaprine HCl ameliorates OVA-induced asthma through modulating the TLR4\/MyD88\/NF-\u03baB and PI3K\/AKT\/mTOR signaling pathways. Int Immunopharmacol. 2025;163:115249. https:\/\/doi.org\/10.1016\/j.intimp.2025.115249.","journal-title":"Int Immunopharmacol"},{"key":"1398_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156418","volume":"138","author":"X Zhang","year":"2025","unstructured":"Zhang X, Yang L, Feng K, Zhang H, Chen Y, Li W, et al. Shuxuening injection improves myocardial injury after myocardial infarction by regulating macrophage polarization via the TLR4\/NF-\u03baB and PI3K\/Akt signaling pathways. Phytomedicine. 2025;138:156418. https:\/\/doi.org\/10.1016\/j.phymed.2025.156418.","journal-title":"Phytomedicine"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01398-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01398-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:40:52Z","timestamp":1780022452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01398-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01398-w","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}